Serum exosomal miRNA-145 and miRNA-200c as promising biomarkers for preoperative diagnosis of ovarian carcinomas. (Q64991304)

http://europepmc.org/abstract/PMC/6548168

2 July 2019

title

Serum exosomal miRNA-145 and miRNA-200c as promising biomarkers for preoperative diagnosis of ovarian carcinomas. (English)

1 reference

http://europepmc.org/abstract/PMC/6548168

2 July 2019

1 reference

Sewha Kim

1

1 reference

http://europepmc.org/abstract/PMC/6548168

2 July 2019

Min Chul Choi

2

1 reference

http://europepmc.org/abstract/PMC/6548168

2 July 2019

Ju-Yeon Jeong

3

1 reference

http://europepmc.org/abstract/PMC/6548168

2 July 2019

Sohyun Hwang

4

1 reference

http://europepmc.org/abstract/PMC/6548168

2 July 2019

Sang Geun Jung

5

1 reference

http://europepmc.org/abstract/PMC/6548168

2 July 2019

Won Duk Joo

6

1 reference

http://europepmc.org/abstract/PMC/6548168

2 July 2019

Hyun Park

7

1 reference

http://europepmc.org/abstract/PMC/6548168

2 July 2019

Seung Hoon Song

8

1 reference

http://europepmc.org/abstract/PMC/6548168

2 July 2019

Chan Lee

9

1 reference

http://europepmc.org/abstract/PMC/6548168

2 July 2019

Tae Hoen Kim

10

1 reference

http://europepmc.org/abstract/PMC/6548168

2 July 2019

Hee-Jung An

11

1 reference

http://europepmc.org/abstract/PMC/6548168

2 July 2019

publication date

12 May 2019

1 reference

http://europepmc.org/abstract/PMC/6548168

2 July 2019

published in

Journal of Cancer

1 reference

http://europepmc.org/abstract/PMC/6548168

2 July 2019

volume

10

1 reference

http://europepmc.org/abstract/PMC/6548168

2 July 2019

issue

9

1 reference

http://europepmc.org/abstract/PMC/6548168

2 July 2019

page(s)

1958-1967

1 reference

http://europepmc.org/abstract/PMC/6548168

2 July 2019

cites work

Malignant effusions and immunogenic tumour-derived exosomes

1 reference

https://pubmed.ncbi.nlm.nih.gov/31205555

12 December 2020

MicroRNAs: genomics, biogenesis, mechanism, and function

1 reference

https://pubmed.ncbi.nlm.nih.gov/31205555

12 December 2020

Purification, characterization and biological significance of tumor-derived exosomes.

1 reference

https://pubmed.ncbi.nlm.nih.gov/31205555

12 December 2020

Human tumor-released microvesicles promote the differentiation of myeloid cells with transforming growth factor-beta-mediated suppressive activity on T lymphocytes

1 reference

https://pubmed.ncbi.nlm.nih.gov/31205555

12 December 2020

MicroRNA expression profiles in serous ovarian carcinoma.

1 reference

https://pubmed.ncbi.nlm.nih.gov/31205555

12 December 2020

MicroRNA signatures of tumor-derived exosomes as diagnostic biomarkers of ovarian cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/31205555

12 December 2020

Exosomal microRNA: a diagnostic marker for lung cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/31205555

12 December 2020

Comparison of a novel multiple marker assay vs the Risk of Malignancy Index for the prediction of epithelial ovarian cancer in patients with a pelvic mass

1 reference

https://pubmed.ncbi.nlm.nih.gov/31205555

12 December 2020

The widespread regulation of microRNA biogenesis, function and decay

1 reference

https://pubmed.ncbi.nlm.nih.gov/31205555

12 December 2020

Selective release of microRNA species from normal and malignant mammary epithelial cells

1 reference

https://pubmed.ncbi.nlm.nih.gov/31205555

12 December 2020

Multiple recognition assay reveals prostasomes as promising plasma biomarkers for prostate cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/31205555

12 December 2020

Cancer statistics, 2012

1 reference

https://pubmed.ncbi.nlm.nih.gov/31205555

12 December 2020

The majority of microRNAs detectable in serum and saliva is concentrated in exosomes

1 reference

https://pubmed.ncbi.nlm.nih.gov/31205555

12 December 2020

Exosomes: current knowledge of their composition, biological functions, and diagnostic and therapeutic potentials.

1 reference

https://pubmed.ncbi.nlm.nih.gov/31205555

12 December 2020

Evaluation of HE4, CA125, risk of ovarian malignancy algorithm (ROMA) and risk of malignancy index (RMI) as diagnostic tools of epithelial ovarian cancer in patients with a pelvic mass

1 reference

https://pubmed.ncbi.nlm.nih.gov/31205555

12 December 2020

Clinical impact of serum exosomal microRNA-21 as a clinical biomarker in human esophageal squamous cell carcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/31205555

12 December 2020

Cancer statistics, 2013

1 reference

https://pubmed.ncbi.nlm.nih.gov/31205555

12 December 2020

Exosomal miRNAs as Biomarkers for Prostate Cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/31205555

12 December 2020

Identification of circulating microRNA signatures for breast cancer detection

1 reference

https://pubmed.ncbi.nlm.nih.gov/31205555

12 December 2020

Global miRNA expression analysis of serous and clear cell ovarian carcinomas identifies differentially expressed miRNAs including miR-200c-3p as a prognostic marker

1 reference

https://pubmed.ncbi.nlm.nih.gov/31205555

12 December 2020

Characterization of microRNA expression in serous ovarian carcinoma.

1 reference

https://pubmed.ncbi.nlm.nih.gov/31205555

12 December 2020

Clinically relevant microRNAs in ovarian cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/31205555

12 December 2020

miR-145, targeting high-mobility group A2, is a powerful predictor of patient outcome in ovarian carcinoma.

1 reference

https://pubmed.ncbi.nlm.nih.gov/31205555

12 December 2020

The microRNA-200 family: small molecules with novel roles in cancer development, progression and therapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/31205555

12 December 2020

Tumor microRNA expression profiling identifies circulating microRNAs for early breast cancer detection.

1 reference

https://pubmed.ncbi.nlm.nih.gov/31205555

12 December 2020

Exosomes: Emerging biomarkers and targets for ovarian cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/31205555

12 December 2020

The miR-200 Family: Versatile Players in Epithelial Ovarian Cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/31205555

12 December 2020

MicroRNA-200c and microRNA-31 regulate proliferation, colony formation, migration and invasion in serous ovarian cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/31205555

12 December 2020

Tissue-specific and plasma microRNA profiles could be promising biomarkers of histological classification and TNM stage in non-small cell lung cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/31205555

12 December 2020

Clinical relevance of circulating cell-free microRNAs in ovarian cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/31205555

12 December 2020

miRNA-145 inhibits VSMC proliferation by targeting CD40

1 reference

https://pubmed.ncbi.nlm.nih.gov/31205555

12 December 2020

Differential expression of exosomal miRNAs between breast cancer patients with and without recurrence

1 reference

https://pubmed.ncbi.nlm.nih.gov/31205555

12 December 2020

MicroRNA-145 Impedes Thrombus Formation via Targeting Tissue Factor in Venous Thrombosis

1 reference

https://pubmed.ncbi.nlm.nih.gov/31205555

12 December 2020

Cancer statistics, 2018.

1 reference

https://pubmed.ncbi.nlm.nih.gov/31205555

12 December 2020

Identifiers

DOI

10.7150/JCA.30231

1 reference

http://europepmc.org/abstract/PMC/6548168

2 July 2019

PMC publication ID

6548168

1 reference

http://europepmc.org/abstract/PMC/6548168

2 July 2019

PubMed publication ID

31205555

1 reference